FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2023574403> ?p ?o ?g. }

• W2023574403 endingPage "10" @default.
• W2023574403 startingPage "1" @default.
• W2023574403 abstract "Although the combination of herpes simplex virus type 1 (HSV-1) thymidine kinase (TK) with ganciclovir (GCV) has been shown as a promising suicide gene treatment strategy for glioma, the almost immunodepressive dose of GCV required for its adequate in vivo efficacy has hampered its further clinical application. Therefore, In order to reduce the GCV dose required, we aim to compare the therapeutic efficacy of HSV1-sr39TK, an HSV1-TK mutant with increased GCV prodrug catalytic activity, with wildtype TK in C6 glioma cells. Accordingly, rat C6 glioma cells were first transfected with pCDNA-TK and pCDNA-sr39TK, respectively, and the gene transfection efficacy was verified by immunocytochemistry and western blot analysis. Then the in vivo sensitivity of these transfected C6-TK and C6-sr39TK cells to GCV was determined by 3-(4,5)-dimethylthiahiazo-(-z-y1)-3,5-di-phenytetrazoliumromide (MTT) colorimetric assay and Hoechst-propidium iodide (PI) staining. Finally, a subcutaneously C6 xenograft tumor model was established in the nude mice to test the in vitro efficacy of TK/GCV gene therapy. Our results showed that, as compared with wildtype TK, HSV1-sr39TK/GCV demonstrated a stronger therapeutic efficacy against C6 glioma both in vitro and in vivo, which, by reducing the required GCV dose, might warrant its future use in the treatment of glioma under clinical setting." @default.
• W2023574403 created "2016-06-24" @default.
• W2023574403 creator A5003123045 @default.
• W2023574403 creator A5010576526 @default.
• W2023574403 creator A5036526021 @default.
• W2023574403 creator A5043988805 @default.
• W2023574403 creator A5062885337 @default.
• W2023574403 creator A5064934325 @default.
• W2023574403 date "2013-01-01" @default.
• W2023574403 modified "2023-10-14" @default.
• W2023574403 title "Gene Therapy with HSV1-sr39TK/GCV Exhibits a Stronger Therapeutic Efficacy Than HSV1-TK/GCV in Rat C6 Glioma Cells" @default.
• W2023574403 cites W1863752562 @default.
• W2023574403 cites W1909341276 @default.
• W2023574403 cites W1964598686 @default.
• W2023574403 cites W1965101458 @default.
• W2023574403 cites W1979921359 @default.
• W2023574403 cites W1984948650 @default.
• W2023574403 cites W1987222851 @default.
• W2023574403 cites W1992322591 @default.
• W2023574403 cites W1994216715 @default.
• W2023574403 cites W2003232012 @default.
• W2023574403 cites W2008329974 @default.
• W2023574403 cites W2012013941 @default.
• W2023574403 cites W2033642093 @default.
• W2023574403 cites W2045360603 @default.
• W2023574403 cites W2049309316 @default.
• W2023574403 cites W2063564993 @default.
• W2023574403 cites W2065198720 @default.
• W2023574403 cites W2071785782 @default.
• W2023574403 cites W2077687604 @default.
• W2023574403 cites W2086311050 @default.
• W2023574403 cites W2088363130 @default.
• W2023574403 cites W2095109478 @default.
• W2023574403 cites W2098850271 @default.
• W2023574403 cites W2102236923 @default.
• W2023574403 cites W2120654325 @default.
• W2023574403 cites W2131049902 @default.
• W2023574403 cites W2313220981 @default.
• W2023574403 cites W2322540261 @default.
• W2023574403 cites W2323724451 @default.
• W2023574403 cites W2326007239 @default.
• W2023574403 cites W4233610165 @default.
• W2023574403 doi "https://doi.org/10.1155/2013/951343" @default.
• W2023574403 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3603674" @default.
• W2023574403 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23533367" @default.
• W2023574403 hasPublicationYear "2013" @default.
• W2023574403 type Work @default.
• W2023574403 sameAs 2023574403 @default.
• W2023574403 citedByCount "7" @default.
• W2023574403 countsByYear W20235744032014 @default.
• W2023574403 countsByYear W20235744032016 @default.
• W2023574403 countsByYear W20235744032019 @default.
• W2023574403 countsByYear W20235744032022 @default.
• W2023574403 crossrefType "journal-article" @default.
• W2023574403 hasAuthorship W2023574403A5003123045 @default.
• W2023574403 hasAuthorship W2023574403A5010576526 @default.
• W2023574403 hasAuthorship W2023574403A5036526021 @default.
• W2023574403 hasAuthorship W2023574403A5043988805 @default.
• W2023574403 hasAuthorship W2023574403A5062885337 @default.
• W2023574403 hasAuthorship W2023574403A5064934325 @default.
• W2023574403 hasBestOaLocation W20235744031 @default.
• W2023574403 hasConcept C104317684 @default.
• W2023574403 hasConcept C111599444 @default.
• W2023574403 hasConcept C150903083 @default.
• W2023574403 hasConcept C153911025 @default.
• W2023574403 hasConcept C159047783 @default.
• W2023574403 hasConcept C185592680 @default.
• W2023574403 hasConcept C207001950 @default.
• W2023574403 hasConcept C2522874641 @default.
• W2023574403 hasConcept C2776147627 @default.
• W2023574403 hasConcept C2777965375 @default.
• W2023574403 hasConcept C2778227246 @default.
• W2023574403 hasConcept C2779820661 @default.
• W2023574403 hasConcept C2781196997 @default.
• W2023574403 hasConcept C34981463 @default.
• W2023574403 hasConcept C502942594 @default.
• W2023574403 hasConcept C54009773 @default.
• W2023574403 hasConcept C54355233 @default.
• W2023574403 hasConcept C55493867 @default.
• W2023574403 hasConcept C71924100 @default.
• W2023574403 hasConcept C81885089 @default.
• W2023574403 hasConcept C86803240 @default.
• W2023574403 hasConceptScore W2023574403C104317684 @default.
• W2023574403 hasConceptScore W2023574403C111599444 @default.
• W2023574403 hasConceptScore W2023574403C150903083 @default.
• W2023574403 hasConceptScore W2023574403C153911025 @default.
• W2023574403 hasConceptScore W2023574403C159047783 @default.
• W2023574403 hasConceptScore W2023574403C185592680 @default.
• W2023574403 hasConceptScore W2023574403C207001950 @default.
• W2023574403 hasConceptScore W2023574403C2522874641 @default.
• W2023574403 hasConceptScore W2023574403C2776147627 @default.
• W2023574403 hasConceptScore W2023574403C2777965375 @default.
• W2023574403 hasConceptScore W2023574403C2778227246 @default.
• W2023574403 hasConceptScore W2023574403C2779820661 @default.
• W2023574403 hasConceptScore W2023574403C2781196997 @default.
• W2023574403 hasConceptScore W2023574403C34981463 @default.
• W2023574403 hasConceptScore W2023574403C502942594 @default.
• W2023574403 hasConceptScore W2023574403C54009773 @default.

• next